EUCTR2009-017409-13-DE进行中（未招募）1 期
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients - Apotransferrin replacement in atransferrinemia
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Established diagnosis of atransferrinemia, defined as serum levels of transferrin below 40 mg/dl
- •2. Informed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 5
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Known with allergic reactions against human plasma or plasma products
- •2. Having detectable anti-IgA antibodies
研究者
相似试验
招募中
2 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemia2024-515986-33-00Prothya Biosolutions Netherlands B.V.5
招募中
1 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemiaCongenital atransferrinaemia/ hypotransferrinaemiaMedDRA version: 23.1Level: PTClassification code: 10084860Term: Hypotransferrinaemia Class: 100000004851MedDRA version: 23.0Level: LLTClassification code: 10083978Term: Congenital atransferrinaemia Class: 10010331MedDRA version: 20.0Level: PTClassification code: 10044356Term: Transferrin decreased Class: 100000004848MedDRA version: 21.0Level: PTClassification code: 10065973Term: Iron overload Class: 100000004861MedDRA version: 20.0Level: LLTClassification code: 10055212Term: Hypochromic microcytic anemia Class: 10005329MedDRA version: 21.0Level: PTClassification code: 10005620Term: Blood iron increased Class: 100000004848CTIS2024-515986-33-00Prothya Biosolutions Netherlands B.V.4
进行中（未招募）
不适用
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients. Estudio de escalada de dosis para evaluar la farmacocinÊtica, la eficacia y la seguridad de apotransferrina, en pacientes con atransferrinemia. - Apotransferrin replacement in atransferrinemiaAtransferrinemiaMedDRA version: 12.1Level: LLTClassification code 10044357Term: Transferrin increasedMedDRA version: 12.1Level: LLTClassification code 10005620Term: Blood iron increasedMedDRA version: 12.1Level: LLTClassification code 10002272Term: AnemiaEUCTR2009-017409-13-ESSanquin Plasma Products
招募中
不适用
Dose escalation trial to evaluate the safety and the efficacy on new bone formation of a single local treatment with lithium carbonate to teeth extraction sockets for dental implant in Japanese participantsJPRN-UMIN000008795Kyushu University Hospital12
进行中（未招募）
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-000535-36-CZAbbott GmbH & Co. KG100